Larimar Therapeutics Inc banner

Larimar Therapeutics Inc
NASDAQ:LRMR

Watchlist Manager
Larimar Therapeutics Inc Logo
Larimar Therapeutics Inc
NASDAQ:LRMR
Watchlist
Price: 3.42 USD 1.48% Market Closed
Market Cap: $292.7m

Wall Street
Price Targets

LRMR Price Targets Summary
Larimar Therapeutics Inc

Wall Street analysts forecast LRMR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LRMR is 15.5 USD with a low forecast of 7.07 USD and a high forecast of 27.3 USD.

Lowest
Price Target
7.07 USD
107% Upside
Average
Price Target
15.5 USD
353% Upside
Highest
Price Target
27.3 USD
698% Upside
Larimar Therapeutics Inc Competitors:
Price Targets
ZEAL
Zealand Pharma A/S
71% Upside
PTGX
Protagonist Therapeutics Inc
24% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-96%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-96%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LRMR's stock price target?
Price Target
15.5 USD

According to Wall Street analysts, the average 1-year price target for LRMR is 15.5 USD with a low forecast of 7.07 USD and a high forecast of 27.3 USD.

Back to Top